CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...
Phase 3
Portland, Oregon, United States and 108 other locations
This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...
Phase 3
Portland, Oregon, United States and 123 other locations
COVID-19 patients who develop severe disease often develop acute respiratory distress syndrome (ARDS) as a result of a dysregulated...
Phase 2, Phase 3
Portland, Oregon, United States and 19 other locations
The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...
Phase 3
Portland, Oregon, United States and 217 other locations
Performance of the LumiraDx SARS-CoV-2 Ag ULTRA assay will be assessed by comparison to a reference method
Gresham, Oregon, United States and 5 other locations
is to assess the safety and efficacy of leronlimab (PRO 140) administered as weekly subcutaneous injection in subjects with severe or critical COVID...
Phase 2
Portland, Oregon, United States and 17 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Portland, Oregon, United States and 59 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 2, Phase 3
Gresham, Oregon, United States and 114 other locations
The mRNA-1273 vaccine is being developed to prevent COVID-19, the disease resulting from Severe Acute Respiratory Syndrome coronavi...
Phase 2, Phase 3
Gresham, Oregon, United States and 52 other locations
chain reaction [RT-PCR] test) and have coronavirus disease 2019 (COVID-19) symptom(s) with S-217622 tablets compared with placebo t...
Phase 3
Gresham, Oregon, United States and 97 other locations
Clinical trials
Research sites
Resources
Legal